Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Summary
This version uses full terminology and flows well for a research proposal or paper. Primary Objective: To compare the intervention effects of an "AI-based management model," a "customized active follow-up model," and a "conventional patient education and follow-up model" on anxiety and depression in patients. Secondary Objectives: To evaluate the impact of these models on patients' quality of life (QoL), patient-reported adverse events, medication adherence, serological markers, progression-free survival (PFS), and overall survival (OS).
Official title: Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy: A Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2025-07-05
Completion Date
2026-05-30
Last Updated
2026-02-13
Healthy Volunteers
No
Interventions
The "Zhiliao Doctor" AI management platform
Participants in Group A will receive standard clinical care supplemented by the 'Zhiliao Doctor' AI management platform. This 24/7 intelligent platform provides emotional companionship, medication reminders, and adverse reaction assessment based on CTCAE standards to enhance self-management and quality of life.
Tailored Active Follow-up Strategy
Participants receive tailored active follow-up, including personalized phone calls and SMS messages, managed by a professional follow-up center.
Locations (1)
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China